BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24480558)

  • 21. Non-coding RNA: a new tool for the diagnosis, prognosis, and therapy of small cell lung cancer.
    Huang J; Peng J; Guo L
    J Thorac Oncol; 2015 Jan; 10(1):28-37. PubMed ID: 25654726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice.
    McNair AG; Blazeby JM
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):559-67. PubMed ID: 19941433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of finding benefit after lung cancer diagnosis.
    Thornton AA; Owen JE; Kernstine K; Koczywas M; Grannis F; Cristea M; Reckamp K; Stanton AL
    Psychooncology; 2012 Apr; 21(4):365-73. PubMed ID: 21254308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes in randomised controlled trials in prevention and management of carious lesions: a systematic review.
    Levey C; Innes N; Schwendicke F; Lamont T; Göstemeyer G
    Trials; 2017 Nov; 18(1):515. PubMed ID: 29096680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement and management of health-related quality of life in lung cancer.
    Davis K; Yount S; Wagner L; Cella D
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):533-40. PubMed ID: 16163227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychological Burden Associated With Lung Cancer Screening: A Systematic Review.
    Wu GX; Raz DJ; Brown L; Sun V
    Clin Lung Cancer; 2016 Sep; 17(5):315-324. PubMed ID: 27130469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Karnofsky Award 2016: A Lung Cancer Journey, 1973 to 2016.
    Bunn PA
    J Clin Oncol; 2017 Jan; 35(2):243-252. PubMed ID: 28056194
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recent Advances and Future Strategies for Small Cell Lung Cancer].
    Shao W; Wang X; Liu D
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):421-426. PubMed ID: 28641701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of quality of life in patients with non-small-cell lung cancer.
    Camps C; del Pozo N; Blasco A; Blasco P; Sirera R
    Clin Lung Cancer; 2009 Mar; 10(2):83-90. PubMed ID: 19362950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concealment of lung cancer diagnosis: prevalence and correlates.
    Gonzalez BD; Jim HS; Cessna JM; Small BJ; Sutton SK; Jacobsen PB
    Psychooncology; 2015 Dec; 24(12):1774-83. PubMed ID: 25753772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do we need randomised trials to evaluate diagnostic procedures? For.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):129-31. PubMed ID: 14647984
    [No Abstract]   [Full Text] [Related]  

  • 32. Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design.
    Paesmans M; Grigoriu B; Ocak S; Roelandts M; Lafitte JJ; Holbrechts S; Berghmans T; Meert AP; Moretti L; Danyi S; Pasleau F; Ameye L; Van Meerhaeghe A; Sculier JP
    Eur Respir J; 2015 Feb; 45(2):511-24. PubMed ID: 25537559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small cell lung cancer. Clinical practice guidelines in oncology.
    National, Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Mar; 2(2):134-57. PubMed ID: 19777703
    [No Abstract]   [Full Text] [Related]  

  • 34. Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians.
    Gironés R
    J Cancer Educ; 2015 Dec; 30(4):766-73. PubMed ID: 25428838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Review of quality of life assessment methods in patients with non-small cell lung cancer].
    Wachowicz M; Furmanik F
    Pneumonol Alergol Pol; 2002; 70(11-12):608-16. PubMed ID: 12884571
    [No Abstract]   [Full Text] [Related]  

  • 36. A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.
    Tanvetyanon T; Soares HP; Djulbegovic B; Jacobsen PB; Bepler G
    J Thorac Oncol; 2007 Dec; 2(12):1091-7. PubMed ID: 18090580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Sørensen M; Felip E;
    Ann Oncol; 2009 May; 20 Suppl 4():71-2. PubMed ID: 19454469
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of small cell lung cancer: limited disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
    Holbrechts S; Roelandts M;
    Rev Med Brux; 2014; 35(3):160-3. PubMed ID: 25102582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample sizes for randomized trials measuring quality of life in cancer patients.
    Julious SA; George S; Machin D; Stephens RJ
    Qual Life Res; 1997 Mar; 6(2):109-17. PubMed ID: 9161110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
    Fallowfield LJ; Harper P
    Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.